Smoking cessation lowers risk of AFib
Smoking cessation can significantly reduce a person’s risk of developing atrial fibrillation compared to those who continue smoking. Researchers reported this finding on Sept. 11 in JACC: Clinical… read more.
Smoking cessation can significantly reduce a person’s risk of developing atrial fibrillation compared to those who continue smoking. Researchers reported this finding on Sept. 11 in JACC: Clinical… read more.
Over-the-counter blood pressure measuring devices offer a simple, affordable way for people to track hypertension at home, but the standard arm-size ranges for these devices won’t appropriately fit… read more.
According to research presented at ESC Congress 2024,1 women with endometriosis have a 20% greater risk of significant cardiac outcomes compared with women without endometriosis. “For decades, cardiovascular… read more.
Catheter Precision, Inc. announced that at the recently held European Society of Cardiology (ESC) Symposium, interim results demonstrating the use of VIVO in localizing the site of origin… read more.
Up to 74% of adults with treatment-resistant high blood pressure were able to get their blood pressure below 140/90 mm HG within one year through a program combining… read more.
Detailed results from the Phase III study FINEARTS-HF demonstrate that compared to placebo, finerenone (Kerendia/ Firialta) showed a statistically significant improvement in cardiovascular outcomes in patients with heart… read more.
Compared to placebo-treated patients with heart failure and mildly reduced or preserved ejection fraction, similar patients treated with finerone have achieved a significantly lower rate of a composite… read more.
Rates of hypertensive disorders of pregnancy (HDP) have increased in Canada, but the good news is there has been a decline in some related-health conditions, according to new… read more.
According to research presented today at ESC Congress 2024, 1 patients with stable coronary artery disease who quit smoking at any timepoint after their diagnosis reduced their risk… read more.
New research presented at the ESC Congress 2024 in London, UK (30 August – 2 September) shows that women in the menopause transition period show changes in their… read more.
Abbott announced that the FDA has approved a change to its label that will help patients who receive a HeartMate 3 left ventricular assist device (LVAD, or heart… read more.
scPharmaceuticals Inc. announced that the FDA has approved its Supplemental New Drug Application (sNDA) seeking to expand the Furoscix indication for heart failure patients. At approval, Furoscix was… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.